BioSerenity is a medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases such as epilepsy. The medical devices are composed of medical sensors, smart clothing or consumables, a smartphone app for Patient Reported Outcome, and a web platform to perform data analysis through Medical Artificial Intelligence for detection of digital biomarkers. The company initially focused on Neurology, a domain in which it reported contributing to the diagnosis of 30 000 patients per year. It now also operates in Sleep Disorders and Cardiology. BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics.
Company history
BioSerenity was founded in 2014, by Pierre-Yves Frouin. The company was initially hosted at the ICM Institute (Institute du Cerveau et de la Moëlle épinière), in Paris, France.
Fund Raising
- June 8, 2015 : The company raised a $4 million seed round with Kurma Partners and IdInvest Partners
- September 20, 2017 : The company raised a $17 million series
…
Source: Wikipedia
No Comments yet!